46
Quality Score
Emerging
NCCN Reimbursement Resource
✍️ bumetric analysis
“
NCCN Reimbursement Resource is an Android app from National Comprehensive Cancer Network (NCCN) in the Medical category, currently rated 4.0★ across 19 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.
Quality Score is 46: Emerging (early traction worth watching). For a Medical app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Revenue · today and ahead
Today
$500/mo
In 12 months
$437 – $1575
In 24 months
$405 – $3644
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$500/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$426 – $993
12 months
$437 – $1.6K
24 months
$405 – $3.6K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Early-stage solo · 41/100INDIE TIERexpected for tierRevenue Strength
2.7
Product Quality
3.2
Market Position
0.0
Growth Velocity
5.0
Defensibility
6.0
Operational Safety
10.0
Founder Strength
4.7
Monetization Maturity
1.0
- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.0★ across 19 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $9K-$16K. Portfolio play ($997/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
🧪
Tech & Domain Intel — nccn.org
- Tech stack
- Microsoft 365 · Google Workspace · AWS SES
Derived from public RDAP + DNS TXT records (no scraping, no login).
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 4 of 4 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Mature app (11y old)METRIC | +$1,500 | |
| Good rating (4.0★)METRIC | +$800 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Pre-traction phase (19 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
App Specs
🔐 Own this app? Claim & verify MRR →🔖 vVaries with device📂 Medical💰 Free🚀 Launched 2014 (11y old)
📝 About this app
The oncology reimbursement landscape continues to present ever-evolving challenges for clinicians and others who work with patients with cancer. As a response to these ongoing challenges, help is available through the NCCN Reimbursement Resource App.
Users can select a cancer or supportive care indication, search by drug name, or select a reimbursement or assistance program to learn about available reimbursement help and services to help mitigate reimbursement challenges.
Users can select a cancer or supportive care indication, search by drug name, or select a reimbursement or assistance program to learn about available reimbursement help and services to help mitigate reimbursement challenges.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- NCCN Reimbursement Resource
- Developer
- National Comprehensive Cancer Network (NCCN)
- Bundle ID
- com.nccn.canassist
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.nccn.org
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $133/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth19 ratings+36% lifetimeShow 3-year history estimate ▾
Tracked (1 weeks) Pre-tracking estimate (36 weeks) · model-based, ±5% noise · anchored to release date and current value
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
More by National Comprehensive Cancer Network (NCCN)
View all →📦 Portfolio summaryINDIE studio
4apps·$997/mocombined
Lead-app heavy — top app contributes 59%
Full revenue analysis
Read the article-style breakdown for NCCN Reimbursement Resource: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.